In a head-to-head clinical trial, cholesterol-lowering rosuvastatin and atorvastatin were equally effective at preventing heart attacks, strokes, death and cardiac revascularization.
Dr. David Kim was recently appointed CEO of MemorialCare Medical Foundation and will serve as chief executive of the MemorialCare Heart & Vascular Institute.
A study done on men in the Swedish military indicates that high blood pressure early in life can lead to cardiovascular events such as a heart attack in later years